Brief: Ascelia Pharma Q1 Operating Loss Widens To SEK 36.7 Mln
11/05/2023 06:39
May 11 (Reuters) - Ascelia Pharma AB ACELP.ST :
* QUARTERLY REPORT Q1 2023: ORVIGLANCE PHASE 3 STUDY,
SPARKLE,
LAST PATIENT LAST VISIT (LPLV) HAS BEEN COMPLETED
* Q1 OPERATING RESULT OF SEK -36.7M (SEK -32.6M)
* Q1 CASH FLOW FROM OPERATIONS OF SEK -37.5M (SEK -31.4M)
Source text for Eikon: ID:nMFN6sPfmd
Further company coverage: ACELP.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))